Image

We are Bavarian Nordic

Advancing vaccine innovation to meet evolving health threats, support providers, and help protect the patients you serve

About Us

We’re a global vaccines company on a mission to help improve and protect lives from infectious diseases through innovative vaccines.

Our Vaccine Portfolio

RabAvert®

(Rabies Vaccine)

Vimkunya™

(Chikungunya Vaccine, Recombinant, Injection)

Vaxchora®

(Cholera Vaccine, Live, Oral)

JYNNEOS®

(Smallpox and Mpox Vaccine, Live, Non-replicating, Injection)

Vivotif®

(Typhoid Vaccine Live Oral Ty21a)

Diseases We Help Combat

Explore information, resources, and insights to support awareness, prevention, and treatment of infectious diseases impacting public health.

Image

Rabies¹

Found on all continents, except Antarctica. Rabies is a rare but fatal disease caused by a virus that is transmitted to humans from infected animals, usually through a bite or scratch.

Image

Chikungunya²

Found in many popular travel destinations, including 119 countries.

Image

Cholera³

~1.3-4.0 million cases of cholera occur worldwide each year. Up to 143,000 deaths are attributed to cholera worldwide each year.

Image

Mpox⁴

Since the unprecedented global mpox outbreak in 2022, ongoing mpox outbreaks continue to pose a threat.

Image

Typhoid⁵

An estimated 9.2 million cases of typhoid occur worldwide each year, causing an estimated 133,000 people to die from it each year.

Learning Materials

Explore resources, guides, and educational content to help support vaccination conversations.

Image

Exploring Virus-Like Particle Technology

Watch now

Virus-Like Particles (VLPs) are vaccine technology designed to mimic the structure of viruses—without containing the genetic material that makes them infectious.6 In this short video, learn how VLP technology is helping shape the future of vaccine development and why it represents an important step in advancing global health preparedness.

Image

Rabies Post-Exposure Prophylaxis (PEP) in Practice

Watch now

This video is intended to discuss how rabies post-exposure prophylaxis, or PEP, works in practice, using case studies, as well as sharing important do’s and don’ts and additional useful resources.

Image

Prevention of Human Rabies

Watch now

This video discusses the prevention of human rabies, breaking down how to evaluate risk, what constitutes post-exposure prophylaxis, or PEP, and the difference between passive vs. active immunization relating to rabies immune globulin and rabies vaccine when treating a person that’s been exposed to a potentially rabid animal.

Image

Rabies 101

Watch now

This is an explanatory video on the basics of rabies, particularly pertaining to its transmission and epidemiology in the United States, while briefly covering disease development in humans.

Published date: 26 June 2025

  1. “Rabies | Yellow Book.” CDC, 23 April 2025, https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/rabies.html. Accessed 20 August 2025. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/rabies.html
  2. "Disease Outbreak News: Chikungunya virus disease – Global situation." World Health Organisation (WHO), 3 October 2025, Accessed 16 October 2025. https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON581 https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON581
  3. Cholera.” World Health Organization (WHO), 5 December 2024, Accessed 19 August 2025. https://www.who.int/news-room/fact-sheets/detail/cholera https://www.who.int/news-room/fact-sheets/detail/cholera
  4. “Mpox.” World Health Organization (WHO), 26 August 2024, https://www.who.int/news-room/fact-sheets/detail/mpox. Accessed 20 August 2025. https://www.who.int/news-room/fact-sheets/detail/mpox
  5. “Typhoid and Paratyphoid Fever | Yellow Book.” CDC, 23 April 2025, https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/typhoid-and-paratyphoid-fever.html. Accessed 20 August 2025. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/typhoid-and-paratyphoid-fever.html
  6. Laxmi B, et al. "Virus-like particles: Innovative strategies for combatting emerging and re-emerging viral threats." The Microbe. 2025;7:100351.